Last €23.84 EUR
Change Today -0.057 / -0.24%
Volume 391.1K
RHK On Other Exchanges
Symbol
Exchange
Xetra
OTC US
OTC US
As of 1:55 PM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

rhoen-klinikum ag (RHK) Snapshot

Open
€23.95
Previous Close
€23.90
Day High
€24.11
Day Low
€23.84
52 Week High
06/9/14 - €24.87
52 Week Low
10/1/13 - €18.93
Market Cap
3.3B
Average Volume 10 Days
270.1K
EPS TTM
€9.81
Shares Outstanding
138.2M
EX-Date
06/13/14
P/E TM
2.4x
Dividend
€0.25
Dividend Yield
1.05%
Current Stock Chart for RHOEN-KLINIKUM AG (RHK)

Related News

No related news articles were found.

rhoen-klinikum ag (RHK) Related Businessweek News

No Related Businessweek News Found

rhoen-klinikum ag (RHK) Details

RHÖN-KLlNlKUM Aktiengesellschaft provides healthcare services in Germany. As of April 30, 2014, the company had 10 hospitals in 5 locations and a total of 5,300 beds. It also had hospitals in Boizenburg, Cuxhaven, and Waltershausen-Friedrichroda. The company is headquartered in Bad Neustadt a.d. Saale, Germany.

16,325 Employees
Last Reported Date: 08/8/14

rhoen-klinikum ag (RHK) Top Compensated Officers

Chairman of Management Board
Total Annual Compensation: €1.0M
Chief Financial Officer and Member of Managem...
Total Annual Compensation: €733.0K
Member of Management Board and Regional Direc...
Total Annual Compensation: €450.0K
Compensation as of Fiscal Year 2013.

rhoen-klinikum ag (RHK) Key Developments

Rhön-Klinikum AG Announces Settlement of Law Suits with Riebeck-Brauerei von 1862 AG and Rheintex Verwaltungs AG Against Resolutions of the Annual General Meeting 2014

Rhön-Klinikum Aktiengesellschaft announced that in the fast track proceeding (Freigabeverfahren) initiated by the company in order to effect the registration of the resolution of the annual general meeting 2014 on item 3 of the agenda (capital reduction and share repurchase 2014) with the commercial register, the company on the one hand and Riebeck-Brauerei von 1862 AG and Rheintex Verwaltungs AG on the other agreed to a settlement proposal of the Higher Regional Court of N-rnberg. The settlement comprises the amicable ending of the fast track proceeding and the agreement to declare the law suits filed by Riebeck-Brauerei von 1862 AG and Rheintex Verwaltungs AG against the resolutions of the annual general meeting 2014 on item 2 (appropriation of profits) and item 3 (capital reduction and share repurchase 2014) moot (f-r erledigt erkl-ren). Riebeck-Brauerei von 1862 AG and Rheintex Verwaltungs AG expressly consent to the entry of the resolution on capital reduction into the commercial register. The settlement agreement still requires formal determination by resolution of the Higher Regional Court of N-rnberg.

Asklepios Interested Reportedly In Acquisitions Of Hospitals

Asklepios - Asb Krankenhaus Radeberg Gmbh is planning to spend €1 billion on the acquisitions on the acquisition of hospitals, reported German Manager Magazin without disclosing its sources. The report added that Asklepios's sole owner Bernard Broermann is mainly focused on facilities owned by Rhön-Klinikum Aktiengesellschaft (DB:RHK), but he is also interested in the purchase of rehabilitation clinics chain MEDIAN Kliniken GmbH & Co. KG and two hospitals near Leipzig. Asklepios could also try to buy facilities from hospital chains Schön Klinik SE and Sana Kliniken AG.

Rhön-Klinikum AG Announces Earnings Results for the Six Months of 2014; Provides Earnings Guidance for the Financial Year of 2015

Rhön-Klinikum AG announced earnings results for the six months of 2014. The company’s revenues for this period are at EUR 959.1 million, earnings before interest, taxes, depreciation and amortisation (EBITDA) amount to EUR 1.35 billion due to the sales proceeds. As for the first quarter of the current financial year, the financial figures for the first six months were also significantly influenced by the sale to Fresenius/Helios of a total of 40 hospitals and associated facilities. The financial figures for the first six months reflect this extraordinary situation: the financial statement for the first two months of the year was drawn up with the full consolidation of the previous portfolio in its entirety while the reduced portfolio is included since March. Added to this are numerous primarily positive one-off effects but there are also burdens, both of which can generally be attributed to the transaction. The company expects revenues of EUR 1.06 billion to EUR 1.12 billion and earnings before interest, tax, depreciation and amortisation (EBITDA) of between EUR 145 million and EUR 155 million for the coming financial year 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RHK:GR €23.84 EUR -0.057

RHK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Curanum AG €3.93 EUR -0.026
Korian-Medica €29.90 EUR +0.03
Maternus-Kliniken AG €0.34 EUR -0.06
Orpea €49.34 EUR +0.12
View Industry Companies
 

Industry Analysis

RHK

Industry Average

Valuation RHK Industry Range
Price/Earnings 2.5x
Price/Sales 1.2x
Price/Book 1.1x
Price/Cash Flow 2.3x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RHOEN-KLINIKUM AG, please visit www.rhoen-klinikum-ag.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.